| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Docosahexaenoic Acid | Chronic Renal Failure | 2 | PM | 34940691 | 📋 | Influence of Polyunsaturated Fatty Acid Intake on Kidney Functions of Rats with Chronic Renal Failure |
| Docosahexaenoic Acid | Chronic Renal Failure | 1 | PM | 32732154 | 📋 | A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of an Omega-3 Fatty Acid Supplement in Patients With Predialysis Chronic Kidney Disease |
| Docosahexaenoic Acid | Diabetic Nephropathy | 1 | PM | 33835594 | 📋 | Fish oil replacement prevents, while docosahexaenoic acid-derived protectin DX mitigates end-stage-renal-disease in atherosclerotic diabetic mice |
| Docosahexaenoic Acid | Glomerulonephritis | 1 | PM | 36875087 | 📋 | Lipidome modulation by dietary omega-3 polyunsaturated fatty acid supplementation or selective soluble epoxide hydrolase inhibition suppresses rough LPS-accelerated glomerulonephritis in lupus-prone mice |
| Docosahexaenoic Acid | IgA Nephropathy | 2 | PM | 15570035 | 📋 | Docosahexaenoic acid attenuates mycotoxin-induced immunoglobulin a nephropathy, interleukin-6 transcription, and mitogen-activated protein kinase phosphorylation in mice |
| Docosahexaenoic Acid | IgA Nephropathy | 1 | PM | 15173396 | 📋 | Docosahexaenoic acid and eicosapentaenoic acid, but not alpha-linolenic acid, suppress deoxynivalenol-induced experimental IgA nephropathy in mice |
| Docosahexaenoic Acid | Kidney Stones | 1 | PM | 32290564 | 📋 | The Efficacy of Polyunsaturated Fatty Acids as Protectors Against Calcium Oxalate Renal Stone Formation: A Review |
